Abstract:
:Probiotics have seen widespread use for a variety of gastrointestinal problems, especially in two common disorders: irritable bowel syndrome and inflammatory bowel disease. Since a wide variety of probiotic preparations has been used, and despite a large number of studies performed, a great deal of heterogeneity exists among them. Straightforward evidence-based recommendations for the use of probiotics in irritable bowel syndrome and inflammatory bowel disease have thus been difficult to formulate. In an effort to improve understanding of the risk-benefit balance of probiotics in these conditions, this study (1) queried the US FDA Adverse Event Reporting System (FAERS) database for all reported adverse drug events related to probiotics in 2013, and (2) constructed risk-benefit planes for both irritable bowel syndrome and inflammatory bowel disease using a geometric approximation of the confidence region between risk and benefit. The results show that adverse events from probiotics vary widely by disease, and when they occur, they are mild and may be difficult to distinguish from the natural history of the underlying disorders they are used to treat. The risk-benefit plane for irritable bowel syndrome straddles the risk-benefit threshold, so patients can expect a balance between a low chance of risk and also a low chance of benefit. The risk-benefit plane for inflammatory bowel disease largely lies above the risk-benefit threshold, so patients may expect more benefit than risk in most cases. More standardized and high-quality research is needed to improve our understanding of risk and benefit for these complex biopharmaceuticals.
journal_name
Drug Safjournal_title
Drug safetyauthors
Bennett WE Jrdoi
10.1007/s40264-015-0349-xsubject
Has Abstractpub_date
2016-04-01 00:00:00pages
295-305issue
4eissn
0114-5916issn
1179-1942pii
10.1007/s40264-015-0349-xjournal_volume
39pub_type
杂志文章,评审相关文献
DRUG SAFETY文献大全abstract::Although the aetiology of inflammatory bowel disease remains elusive, many agents are available for the control of symptoms and inflammation. Knowledge of drug pharmacology, indications and side effects is essential to ensure the best possible clinical care while minimising toxicity and inappropriate use. Sulfasalazin...
journal_title:Drug safety
pub_type: 杂志文章,评审
doi:10.2165/00002018-199106030-00005
更新日期:1991-05-01 00:00:00
abstract::It is a major clinical and public health problem that there is no clear strategy as to how we best make use of information obtained when pregnant women take drugs. For this reason, some pregnant women are not treated as they should be and some are given drugs they should not use. We suggest a monitoring system that co...
journal_title:Drug safety
pub_type: 杂志文章
doi:10.2165/00002018-200225010-00003
更新日期:2002-01-01 00:00:00
abstract::The prognosis is generally poor for patients who experience a cardiac arrest. The most common causes of sudden cardiac arrest are massive pulmonary embolism (PE) and acute myocardial infarction (MI). While thrombolysis is a first-line treatment option in massive PE and acute MI, cardiopulmonary resuscitation (CPR) has...
journal_title:Drug safety
pub_type: 杂志文章,评审
doi:10.2165/00002018-200326060-00001
更新日期:2003-01-01 00:00:00
abstract::Complex interactions exist amongst the various components of the neuroendocrine system in order to maintain homeostasis, energy balance and reproductive function. These components include the hypothalamus-pituitary- adrenal and -gonadal axes, the renin-angiotensin-aldosterone system, the sympathetic nervous system and...
journal_title:Drug safety
pub_type: 杂志文章,评审
doi:10.2165/00002018-200730030-00005
更新日期:2007-01-01 00:00:00
abstract:INTRODUCTION:While medical chart review remains the gold standard to validate health conditions or events identified in administrative claims and electronic health record databases, it is time consuming, expensive and can involve subjective decisions. AIM:The aim of this study was to describe the landscape of technolo...
journal_title:Drug safety
pub_type: 杂志文章
doi:10.1007/s40264-019-00838-x
更新日期:2019-09-01 00:00:00
abstract:BACKGROUND:The roll out of various public health programmes involving mass administration of medicines calls for the deployment of responsive pharmacovigilance systems to permit identification of signals of rare or even common adverse reactions. In developing countries in Africa, these systems are mostly absent and the...
journal_title:Drug safety
pub_type: 杂志文章
doi:10.2165/00002018-200831100-00005
更新日期:2008-01-01 00:00:00
abstract::Thrombocytopenia has been reported as an adverse reaction of numerous drugs. Vancomycin is often overlooked as a culprit but has been associated with several cases of thrombocytopenia that were not well described in the literature. A literature search was conducted to find reports of thrombocytopenia induced by vancom...
journal_title:Drug safety
pub_type: 杂志文章,评审
doi:10.1007/s40264-016-0469-y
更新日期:2017-01-01 00:00:00
abstract::The non-vitamin K antagonist oral anticoagulants (NOACs) are used for thromboembolic prophylaxis of patients with atrial fibrillation and in the treatment as well as secondary prophylaxis of patients with venous thromboembolism. Even though NOACs have a better safety profile than vitamin K antagonists (VKAs), there wi...
journal_title:Drug safety
pub_type: 杂志文章,评审
doi:10.1007/s40264-015-0357-x
更新日期:2016-01-01 00:00:00
abstract:INTRODUCTION:Checkpoint inhibitor drugs including ipilimumab have been reported to induce intestinal injury. OBJECTIVE:We aimed to evaluate the risk of chronic (> 6 weeks) enterocolitis following ipilimumab administration, and the likelihood that an enteritis vs colitis or enterocolitis is seen. PATIENTS AND METHODS:...
journal_title:Drug safety
pub_type: 杂志文章,评审
doi:10.1007/s40264-020-00979-4
更新日期:2020-12-01 00:00:00
abstract::Nonsteroidal anti-inflammatory drugs (NSAIDs) are frequently prescribed to women of child-bearing age. Three case series highlight the possibility of a link between NSAIDs and reversible infertility. The pharmacological target of NSAIDs is cyclo-oxygenase (COX), which catalyses the first rate-limiting step in the prod...
journal_title:Drug safety
pub_type: 杂志文章,评审
doi:10.2165/00002018-200225080-00001
更新日期:2002-01-01 00:00:00
abstract:OBJECTIVE:Minocycline is an antibacterial drug used in the treatment of acne. Concern has been expressed over the possibility of severe adverse reactions to minocycline, including hepatitis. This study set out to identify and characterise reported cases of hepatotoxicity associated with the use of minocycline. METHODS...
journal_title:Drug safety
pub_type: 杂志文章
doi:10.2165/00002018-200023040-00006
更新日期:2000-10-01 00:00:00
abstract:INTRODUCTION:Proprotein convertase subtilisin/kexin type 9 inhibitors (PCSK9Is) were associated with a risk of neurocognitive adverse drug reactions (ADRs). OBJECTIVE:We aimed to investigate the occurrence of neuropsychiatric ADRs related to PCSK9Is. METHODS:We analyzed Individual Case Safety Reports (ICSRs) sent thr...
journal_title:Drug safety
pub_type: 杂志文章
doi:10.1007/s40264-020-01021-3
更新日期:2020-12-22 00:00:00
abstract::NSAIDs are widely used to treat pain and inflammation in osteoarthritis. Their use in this indication is generally intermittent and fluctuates with the intensity of the disease. Nonetheless, success of the therapy is frequently limited by injury to the gastrointestinal mucosa and complications such as bleeding, ulcera...
journal_title:Drug safety
pub_type: 杂志文章,评审
doi:10.2165/00002018-200427030-00003
更新日期:2004-01-01 00:00:00
abstract:INTRODUCTION:The epidemiology of naturally occurring intussusception is known to increase significantly between the ages of 3 and 8 months. Post-licensure studies have reported a fivefold and twofold increase in intussusception in the first week after the first dose and second dose, respectively, of current rotavirus v...
journal_title:Drug safety
pub_type: 杂志文章
doi:10.1007/s40264-016-0424-y
更新日期:2016-08-01 00:00:00
abstract:BACKGROUND:Case reports have related the use of HMG-CoA reductase inhibitors ('statins') to Parkinson's disease (PD). Paradoxically, however, statins may have potentially beneficial effects on neurodegenerative diseases due to their anti-inflammatory properties. OBJECTIVE:To explore the risk of the development of PD i...
journal_title:Drug safety
pub_type: 杂志文章
doi:10.2165/00002018-200831050-00004
更新日期:2008-01-01 00:00:00
abstract:BACKGROUND:In November 2009, a vaccination campaign against Influenza A (H1N1) was started in the Netherlands. The accelerated registration procedure of the vaccines used in this campaign and the use of these vaccines on a large scale indicated a need for real-time safety monitoring. OBJECTIVE:To describe the processi...
journal_title:Drug safety
pub_type: 杂志文章
doi:10.2165/11539270-000000000-00000
更新日期:2010-12-01 00:00:00
abstract::Stroke is a very common medical emergency that, until recently, had no specific treatment. Following the results of several major trials (including 2 'mega-trials'), aspirin (acetylsalicylic acid) can be recommended for the majority of patients with acute ischaemic stroke. While the benefit of aspirin is only modest, ...
journal_title:Drug safety
pub_type: 杂志文章,评审
doi:10.2165/00002018-199819050-00004
更新日期:1998-11-01 00:00:00
abstract::The New Zealand Intensive Medicines Monitoring Programme (IMMP) undertakes prospective observational cohort studies on selected new drugs in the early postmarketing period using prescription-event monitoring (PEM) methodology with the purpose of identifying signals of previously unrecognised ADRs and establishing risk...
journal_title:Drug safety
pub_type: 杂志文章
doi:10.2165/00002018-200225060-00007
更新日期:2002-01-01 00:00:00
abstract:INTRODUCTION:Controversy exists about an association between angiotensin-converting-enzyme inhibitors (ACEIs), angiotensin-receptor blockers (ARBs), and thiazides (TZs) and the risk of malignant melanoma (MM), and non-melanoma skin cancer-basal cell carcinoma (BCC) and squamous cell carcinoma (SCC). OBJECTIVE:The aim ...
journal_title:Drug safety
pub_type: 杂志文章
doi:10.1007/s40264-016-0487-9
更新日期:2017-03-01 00:00:00
abstract:BACKGROUND:The case-population approach or population-based case-cohort approach is derived from the case-control design and consists of comparing past exposure to a given risk factor in subjects presenting a given disease or symptom (cases) with the exposure rate to this factor in the whole cohort or in the source pop...
journal_title:Drug safety
pub_type: 杂志文章
doi:10.2165/11592140-000000000-00000
更新日期:2011-10-01 00:00:00
abstract::Randomized controlled trials always report the dose assessed and usually include a measure of adherence. By comparison, observational studies assessing medication safety often fail to report the dose used and rarely report any measure of adherence to therapy. This limits the ability to control for differences in doses...
journal_title:Drug safety
pub_type: 杂志文章,评审
doi:10.1007/s40264-015-0347-z
更新日期:2015-12-01 00:00:00
abstract:INTRODUCTION AND OBJECTIVE:The therapeutic role of fecal microbiota transplantation in ulcerative colitis varies across different reports. This study aims to evaluate the long-term safety and efficacy of a strategy called step-up fecal microbiota transplantation for ulcerative colitis. METHODS:Two clinical trials (NCT...
journal_title:Drug safety
pub_type: 杂志文章
doi:10.1007/s40264-019-00809-2
更新日期:2019-07-01 00:00:00
abstract::The risks and adverse effects of the low dose, new generation progestogen combined oral contraceptives (COCs) are much lower than original studies involving pills containing 50 micrograms estrogen. The main effects are those on the cardiovascular system, lipid and glucose metabolism and cancer. Any effect of the COC o...
journal_title:Drug safety
pub_type: 杂志文章,评审
doi:10.2165/00002018-199512020-00002
更新日期:1995-02-01 00:00:00
abstract::The available antihyperlipidaemic drugs are generally safe and effective, and major systemic adverse effects are uncommon. However, because of their complex mechanisms of action, careful monitoring is required to identify and correct potential drug interactions. Bile acid sequestrants are the most difficult of these a...
journal_title:Drug safety
pub_type: 杂志文章,评审
doi:10.2165/00002018-199411050-00002
更新日期:1994-11-01 00:00:00
abstract::Drug eruptions are among the most common adverse drug reactions, affecting approximately 3% of hospitalised patients. Although the rate of severe cutaneous adverse reactions to medications is low, these reactions can affect anyone who takes medication, and can result in death or disability. Two general patterns can be...
journal_title:Drug safety
pub_type: 杂志文章,评审
doi:10.2165/00002018-200730110-00003
更新日期:2007-01-01 00:00:00
abstract::Adverse drug reactions (ADRs) cause considerable mortality and morbidity but no recent reviews are currently available for the European region. Therefore, we performed a review of all epidemiological studies quantifying ADRs in a European setting that were published between 1 January 2000 and 3 September 2014. Include...
journal_title:Drug safety
pub_type: 杂志文章,评审
doi:10.1007/s40264-015-0281-0
更新日期:2015-05-01 00:00:00
abstract::Boxed warnings-also known as "black box" warnings-can be a powerful tool in communicating drug risks to physicians and patients. The overall number of boxed warnings has grown in recent years as the US Food and Drug Administration (FDA) has approved more drugs on the basis of limited pre-marketing information and as n...
journal_title:Drug safety
pub_type: 杂志文章
doi:10.1007/s40264-016-0419-8
更新日期:2016-08-01 00:00:00
abstract:BACKGROUND:There are no head-to-head randomized controlled trials comparing different direct oral anticoagulants (DOACs). Thus, we systematically reviewed and meta-analyzed observational studies assessing the comparative effectiveness and safety of DOACs for stroke prevention in patients with atrial fibrillation (AF). ...
journal_title:Drug safety
pub_type: 杂志文章,meta分析
doi:10.1007/s40264-019-00842-1
更新日期:2019-10-01 00:00:00
abstract::The New Zealand Medicines Adverse Reactions Committee has been monitoring reports of adverse drug reactions (ADRs) since 1965. We wished to determine the numbers of voluntary reports of different types of ADR to all nonsteroidal anti-inflammatory drugs (NSAIDs) over a long time period and relate these to age. As the e...
journal_title:Drug safety
pub_type: 杂志文章
doi:10.2165/00002018-199207060-00006
更新日期:1992-11-01 00:00:00
abstract:INTRODUCTION:The prevalence of polymorphisms among the metabolising enzymes and pharmacodynamic receptors relevant for the thiazolidinediones differs by ethnic group, a factor that may modify risk of adverse drug events. OBJECTIVE:The aim of the study was to determine if the risk of oedema or heart failure associated ...
journal_title:Drug safety
pub_type: 杂志文章
doi:10.1007/s40264-015-0318-4
更新日期:2015-09-01 00:00:00